FDA Guidance Addresses Wave Of Impurities In Popular Drugs
The U.S. Food and Drug Administration released guidance Tuesday to help drug companies detect and prevent unacceptable levels of nitrosamine impurities, which have been linked to cancer and triggered recalls of...To view the full article, register now.
Already a subscriber? Click here to view full article